TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Alligator Bioscience AB
Closing information (x1000 NOK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
58,864
|
33,765
|
12,622 |
Financial expenses |
1,506
|
611
|
227 |
Earnings before taxes |
-251,826
|
-182,942
|
-138,224 |
EBITDA |
-241,602
|
-171,231
|
-127,189 |
Total assets |
119,994
|
160,412
|
324,944 |
Current assets |
79,207
|
116,171
|
292,189 |
Current liabilities |
100,370
|
61,039
|
46,241 |
Equity capital |
12,009
|
84,235
|
275,279 |
- share capital |
42,720
|
83,821
|
86,048 |
Employees (average) |
56
|
50
|
45 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
10.0%
|
52.5%
|
84.7% |
Turnover per employee |
1,051
|
675
|
280 |
Profit as a percentage of turnover |
-427.8%
|
-541.8%
|
-1095.1% |
Return on assets (ROA) |
-208.6%
|
-113.7%
|
-42.5% |
Current ratio |
78.9%
|
190.3%
|
631.9% |
Return on equity (ROE) |
-2097.0%
|
-217.2%
|
-50.2% |
Change turnover |
22,703
|
21,522
|
8,378 |
Change turnover % |
63%
|
176%
|
197% |
Chg. No. of employees |
6
|
5
|
-5 |
Chg. No. of employees % |
12%
|
11%
|
-10% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.